Rani Therapeutics Holdings, Inc.

RANI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$57-$34-$63-$8
Dep. & Amort.$1$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$16$19$16$23
Change in WC-$1-$2$1-$3
Other Non-Cash$5-$35-$0-$44
Operating Cash Flow-$35-$51-$47-$32
Investing Activities
PP&E Inv.-$0-$1-$2-$1
Net Acquisitions$0$0-$1$0
Inv. Purchases-$59-$73-$74$0
Inv. Sales/Matur.$78$104$3$0
Other Inv. Act.$1$0$1$0
Investing Cash Flow$20$30-$72-$1
Financing Activities
Debt Repay.-$5$0$30-$3
Stock Issued$19$0$0$74
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$1$6
Financing Cash Flow$14$0$29$77
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$21-$90$44
Supplemental Information
Beg. Cash$6$28$117$73
End Cash$4$6$28$117
Free Cash Flow-$36-$52-$48-$33
Rani Therapeutics Holdings, Inc. (RANI) Financial Statements & Key Stats | AlphaPilot